USP13 and prostate carcinoma: The clinicopathological characteristics and USP13 expression of 499 patients with prostate cancer were obtained from TCGA, and the association of USP13 expression and clinicopathological characteristics was analyzed using the chi-square test and Fisher’s exact test (Table 1).